📰 GeneralCNBCFriday, May 29, 2026 at 3:10 AM UTC14h ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines

Why this matters for military families

Developments that affect daily life for service members and their families at duty stations worldwide.

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation.ai.

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Why this matters for military families

📰 Related Stories

Microsoft delays Fable (again) to avoid GTA VI

Galaxy Z Fold 8 series may ‘significantly’ improve the display crease

As SpaceX IPO nears, traders think it's a near-certainty Musk becomes the first trillionaire

Startup offers free home cleaning—if it can record it all for robot training

Cognition’s Scott Wu says AI coding agents shouldn’t replace humans

After years of stability, F1 reliability can no longer be taken for granted